HMC treatment reduced the basal neuronal activation caused by TiO2-induced arthritis as well as the responsiveness of TRPV1+ (Figure 8A,B,E) and TRPA1+ (Figure 8C–E) DRG neurons, which are two important subsets of nociceptive neurons. This evidence concerns the gene TRPA1 and arthritic joint disease.